These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

778 related articles for article (PubMed ID: 18982161)

  • 1. The cytokine network in asthma and chronic obstructive pulmonary disease.
    Barnes PJ
    J Clin Invest; 2008 Nov; 118(11):3546-56. PubMed ID: 18982161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asthma, chronic obstructive pulmonary disease (COPD), and the overlap syndrome.
    Nakawah MO; Hawkins C; Barbandi F
    J Am Board Fam Med; 2013; 26(4):470-7. PubMed ID: 23833163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-9 as a possible therapeutic target in both asthma and chronic obstructive airways disease.
    McNamara PS; Smyth RL
    Drug News Perspect; 2005 Dec; 18(10):615-21. PubMed ID: 16491163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Airway inflammation in chronic obstructive pulmonary disease: comparisons with asthma.
    Sutherland ER; Martin RJ
    J Allergy Clin Immunol; 2003 Nov; 112(5):819-27; quiz 828. PubMed ID: 14610463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agents against cytokine synthesis or receptors.
    Yamagata T; Ichinose M
    Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual role of Toll-like receptors in asthma and chronic obstructive pulmonary disease.
    Bezemer GF; Sagar S; van Bergenhenegouwen J; Georgiou NA; Garssen J; Kraneveld AD; Folkerts G
    Pharmacol Rev; 2012 Apr; 64(2):337-58. PubMed ID: 22407613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective apoptotic cell clearance in asthma and COPD--a new drug target for statins?
    Walsh GM
    Trends Pharmacol Sci; 2008 Jan; 29(1):6-11. PubMed ID: 18054798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunology of asthma and chronic obstructive pulmonary disease.
    Barnes PJ
    Nat Rev Immunol; 2008 Mar; 8(3):183-92. PubMed ID: 18274560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Airway nitrergic pathways: is there therapeutic potential in asthma and COPD?
    Folkerts G; Nijkamp FP
    Curr Opin Pharmacol; 2004 Jun; 4(3):202-6. PubMed ID: 15140409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Innervation of the airways in asthma bronchiale and chronic obstructive pulmonary disease (COPD)].
    Dinh QT; Suhling H; Fischer A; Braun A; Welte T
    Pneumologie; 2011 May; 65(5):283-92. PubMed ID: 21271508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The small airways and distal lung compartment in asthma and COPD: a time for reappraisal.
    Contoli M; Bousquet J; Fabbri LM; Magnussen H; Rabe KF; Siafakas NM; Hamid Q; Kraft M
    Allergy; 2010 Feb; 65(2):141-51. PubMed ID: 19909298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Overlap syndrome--asthma and chronic obstructive pulmonary disease].
    PÅ‚usa T
    Pneumonol Alergol Pol; 2011; 79(5):351-6. PubMed ID: 21861260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases in asthma and COPD.
    Demedts IK; Brusselle GG; Bracke KR; Vermaelen KY; Pauwels RA
    Curr Opin Pharmacol; 2005 Jun; 5(3):257-63. PubMed ID: 15907912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic obstructive pulmonary disease].
    Holzgrabe U; Muth M
    Med Monatsschr Pharm; 2007 May; 30(5):168-76; quiz 177-8. PubMed ID: 17526393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small airway disease in asthma and COPD: clinical implications.
    van den Berge M; Ten Hacken NHT; Cohen J; Douma WR; Postma DS
    Chest; 2011 Feb; 139(2):412-423. PubMed ID: 21285055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies for asthma and chronic obstructive pulmonary disease.
    Antoniu SA
    Expert Opin Biol Ther; 2013 Feb; 13(2):257-68. PubMed ID: 23282002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rho kinase as a therapeutic target in the treatment of asthma and chronic obstructive pulmonary disease.
    Fernandes LB; Henry PJ; Goldie RG
    Ther Adv Respir Dis; 2007 Oct; 1(1):25-33. PubMed ID: 19124345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Airway endothelial dysfunction in asthma and chronic obstructive pulmonary disease: a challenge for future research.
    Wanner A; Mendes ES
    Am J Respir Crit Care Med; 2010 Dec; 182(11):1344-51. PubMed ID: 20709816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential therapeutic role of potassium channel modulators in asthma and chronic obstructive pulmonary disease.
    Malerba M; Radaeli A; Mancuso S; Polosa R
    J Biol Regul Homeost Agents; 2010; 24(2):123-30. PubMed ID: 20487625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical management of chronic obstructive pulmonary disease and asthma in an obese patient.
    Lessard A; Maltais F; Boulet LP
    Expert Opin Pharmacother; 2008 Jan; 9(1):83-93. PubMed ID: 18076340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.